Dissipation kinetics and exposure of spirotetramat and pymetrozine in open fields, a prelude to risk assessment of green bean consumption.

Determination and dissipation kinetics of pymetrozine and spirotetramat in green bean were studied using a QuEChERS method coupled to high-performance liquid chromatography-tandem mass spectrometry. Pymetrozine recoveries ranged between 88.4-93.7%, with relative standard deviation (RSD) of 5.5-14.4%. For spirotetramat the recoveries ranged between 91.7-103.4%, and the RSD were in the range of 3.2 to 12.4%. The limits of quantification (LOQs) were 0.01 mg/kg and 0.005 mg/kg for pymetrozine and spirotetramat, respectively.The developed analytical method was used to study the degradation rates of pymetrozine and spirotetramat in green bean grown in open field. Results showed that pymetrozine and spirotetramat followed the first-order kinetics model with half-lives of 3.3 days and 4.2 days, respectively. Furthermore, risk assessment was carried out which showed that, the chronic risk quotient (RQc) values for pymetrozine and spirotetramat were much lower than 100%. The present results indicated that the health risks posed for consumers by the pymetrozine and spirotetramat residues were negligible at the recommended dosages.

Investigation of the dissipation behaviour and exposure of spitotetramat, flonicamid, imidacloprid and pymetrozine in open field strawberries in Egypt.

The dissipation behaviour and the consumer risk assessment of spitotetramat, flonicamid, imidacloprid and pymetrozine in open field strawberries were studied. Insecticides were applied at the authorised levels and the more critical good agricultural practice regimes (GAP). The initial concentrations varied from 0.069 to 1.75 mg kg-1 depending on the compound, while the dissipation half-lives and terminal residues, 14 days from the last applications, were similar. After application according to the authorised pattern the half-lives were 2.8 days for flonicamid and 3.2 days for spitotetramat, imidacloprid and pymetrozine. The dietary risk assessment, performed using the hazard quotient and the EFSA PRIMo model showed no concern to consumer health with exposure values <2% of the acceptable daily intake (ADI) and <32% of the acute reference dose (ARfD) of each compound.